Page last updated: 2024-11-12

neoechinulin a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

neoechinulin A: from the marine-derived fungus Aspergillus sp.; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9996305
CHEMBL ID400768
MeSH IDM0472904

Synonyms (11)

Synonym
CHEMBL400768
neoechinulin a
(3z,6s)-3-[[2-(1,1-dimethylallyl)-1h-indol-3-yl]methylene]-6-methyl-piperazine-2,5-dione
(3s,6z)-3-methyl-6-[[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene]piperazine-2,5-dione
bdbm50498194
(-)-neoechinulin a; neoechinuline a
MS-24801
CS-0023576
HY-N3204
neoechinulina
AKOS040762103

Research Excerpts

Overview

Neoechinulin A is an indole alkaloid with several biological activities. It exhibits scavenging, neurotrophic factor-like, and anti-apoptotic activities.

ExcerptReferenceRelevance
"Neoechinulin A is an indole alkaloid with several biological activities. "( Identification of proteins that bind to the neuroprotective agent neoechinulin A.
Himeno, N; Kamakura, T; Kamisuki, S; Kuramochi, K; Kusayanagi, T; Sugawara, F; Takeno, M; Tsurukawa, Y, 2018
)
2.16
"Neoechinulin A is an isoprenyl indole alkaloid that exhibits scavenging, neurotrophic factor-like, and anti-apoptotic activities. "( Neoechinulin A induced memory improvements and antidepressant-like effects in mice.
Hoshi, M; Kamisuki, S; Kokaji, A; Kuramochi, K; Niwa, Y; Oka, J; Sasaki-Hamada, S; Sugawara, F; Ueda, Y, 2016
)
3.32

Treatment

Neoechinulin A treatment for more than 12 h endowed PC12 cells with significant resistance to transient NO toxicity. Treatment significantly inhibited the generation of reactive oxygen and nitrogen species in Aβ42-activated microglia cells.

ExcerptReferenceRelevance
"Neoechinulin A treatment for more than 12 h endowed PC12 cells with significant resistance to transient NO toxicity, but not persistent NO toxicity, bolus H₂O₂ toxicity, or oxidative insult from the redox cycling quinone menadione."( Neoechinulin a imparts resistance to acute nitrosative stress in PC12 cells: a potential link of an elevated cellular reserve capacity for pyridine nucleotide redox turnover with cytoprotection.
Akashi, S; Arai, T; Fujieda, S; Kobayashi, S; Konishi, K; Kuramochi, K; Nakagawa, T; Ogura, Y; Okada, T; Shibata, Y; Shirai, K; Sugawara, F; Takahashi, M; Takeuchi, T; Watanabe, N, 2012
)
2.54
"Neoechinulin A treatment significantly inhibited the generation of reactive oxygen and nitrogen species in Aβ42-activated BV-2 microglia cells."( Neoechinulin A suppresses amyloid-β oligomer-induced microglia activation and thereby protects PC-12 cells from inflammation-mediated toxicity.
Dewapriya, P; Himaya, SW; Kim, SK; Li, YX; Pangestuti, R, 2013
)
2.55
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (26)

Assay IDTitleYearJournalArticle
AID1200500Inhibition of influenza A virus A/WSN/33 (H1N1) Hemagglutinin 1 binding to sialic acid receptor assessed as response unit at 5 ug/ml by surface plasmon resonance assay2015European journal of medicinal chemistry, Mar-26, Volume: 93Neoechinulin B and its analogues as potential entry inhibitors of influenza viruses, targeting viral hemagglutinin.
AID1818932Antiviral activity against HCV JFH-1 infected in human Huh-7.5.1 cells assessed as reduction in viral replication measured after 72 hrs by chemiluminescent enzyme immunoassay2022Journal of natural products, 01-28, Volume: 85, Issue:1
Synthesis and Antiviral Activities of Neoechinulin B and Its Derivatives.
AID1818933Cytotoxicity against human Huh-7.5.1 cells assessed as reduction in cell viability measured at 72 hrs by MTT assay2022Journal of natural products, 01-28, Volume: 85, Issue:1
Synthesis and Antiviral Activities of Neoechinulin B and Its Derivatives.
AID311562DPPH radical scavenging activity2007Journal of natural products, Oct, Volume: 70, Issue:10
Isoechinulin-type alkaloids, variecolorins A-L, from halotolerant Aspergillus variecolor.
AID1200493Binding affinity to influenza A virus A/WSN/33 (H1N1) Hemagglutinin 1 binding to sialic acid receptor by surface plasmon resonance assay2015European journal of medicinal chemistry, Mar-26, Volume: 93Neoechinulin B and its analogues as potential entry inhibitors of influenza viruses, targeting viral hemagglutinin.
AID318602Cytotoxicity against human OVCAR-3 cells assessed as concentration required for 50% inhibition2008Journal of natural products, Mar, Volume: 71, Issue:3
Antineoplastic agents. 536. New sources of naturally occurring cancer cell growth inhibitors from marine organisms, terrestrial plants, and microorganisms(1a,).
AID1200501Inhibition of influenza A virus A/WSN/33 (H1N1) Hemagglutinin 1 binding to sialic acid receptor assessed as response unit at 2.5 ug/ml by surface plasmon resonance assay2015European journal of medicinal chemistry, Mar-26, Volume: 93Neoechinulin B and its analogues as potential entry inhibitors of influenza viruses, targeting viral hemagglutinin.
AID1174113Antimycobacterial activity against Mycobacterium tuberculosis H37Ra after 7 days by microplate Alamar blue assay2015European journal of medicinal chemistry, Jan-07, Volume: 89Antimycobacterial activity of natural products and synthetic agents: pyrrolodiquinolines and vermelhotin as anti-tubercular leads against clinical multidrug resistant isolates of Mycobacterium tuberculosis.
AID1200484Cytotoxicity against MDCK cells assessed as cell growth after 40 hrs by CellTiter-Glo assay2015European journal of medicinal chemistry, Mar-26, Volume: 93Neoechinulin B and its analogues as potential entry inhibitors of influenza viruses, targeting viral hemagglutinin.
AID318601Cytotoxicity against mouse P388 cells assessed as concentration required for 50% inhibition2008Journal of natural products, Mar, Volume: 71, Issue:3
Antineoplastic agents. 536. New sources of naturally occurring cancer cell growth inhibitors from marine organisms, terrestrial plants, and microorganisms(1a,).
AID1818936Antiviral activity against SARS-CoV-2 WK-251 infected in African green monkey Vero E6 cells expressing TMPRSS2 assessed as reduction in viral RNA replication incubated for 24 hrs by qRT-PCR analysis2022Journal of natural products, 01-28, Volume: 85, Issue:1
Synthesis and Antiviral Activities of Neoechinulin B and Its Derivatives.
AID1320315Cytotoxicity against mouse B16-4A5 cells assessed as cell number at 100 uM2016Bioorganic & medicinal chemistry letters, 10-15, Volume: 26, Issue:20
Conditional changes enhanced production of bioactive metabolites of marine derived fungus Eurotium rubrum.
AID1818937Cytotoxicity against African green monkey Vero E6 cells expressing TMPRSS2 assessed as reduction in cell viability incubated for 24 hrs by DAPI staining based confocal microscopic analysis2022Journal of natural products, 01-28, Volume: 85, Issue:1
Synthesis and Antiviral Activities of Neoechinulin B and Its Derivatives.
AID318610Cytotoxicity against human SF295 cells assessed as concentration required for 50% inhibition2008Journal of natural products, Mar, Volume: 71, Issue:3
Antineoplastic agents. 536. New sources of naturally occurring cancer cell growth inhibitors from marine organisms, terrestrial plants, and microorganisms(1a,).
AID1200502Inhibition of influenza A virus A/WSN/33 (H1N1) Hemagglutinin 1 binding to sialic acid receptor assessed as response unit at 1.25 ug/ml by surface plasmon resonance assay2015European journal of medicinal chemistry, Mar-26, Volume: 93Neoechinulin B and its analogues as potential entry inhibitors of influenza viruses, targeting viral hemagglutinin.
AID318605Cytotoxicity against human KM20L2 cells assessed as concentration required for 50% inhibition2008Journal of natural products, Mar, Volume: 71, Issue:3
Antineoplastic agents. 536. New sources of naturally occurring cancer cell growth inhibitors from marine organisms, terrestrial plants, and microorganisms(1a,).
AID318604Cytotoxicity against human NCIH460 cells assessed as concentration required for 50% inhibition2008Journal of natural products, Mar, Volume: 71, Issue:3
Antineoplastic agents. 536. New sources of naturally occurring cancer cell growth inhibitors from marine organisms, terrestrial plants, and microorganisms(1a,).
AID1200492Binding affinity to influenza A virus A/WSN/33 (H1N1) Hemagglutinin by surface Plasmon resonance assay2015European journal of medicinal chemistry, Mar-26, Volume: 93Neoechinulin B and its analogues as potential entry inhibitors of influenza viruses, targeting viral hemagglutinin.
AID318611Cytotoxicity against human DU145 cells assessed as concentration required for 50% inhibition2008Journal of natural products, Mar, Volume: 71, Issue:3
Antineoplastic agents. 536. New sources of naturally occurring cancer cell growth inhibitors from marine organisms, terrestrial plants, and microorganisms(1a,).
AID1200503Inhibition of influenza A virus A/WSN/33 (H1N1) Hemagglutinin 1 binding to sialic acid receptor assessed as response unit at 0.625 ug/ml by surface plasmon resonance assay2015European journal of medicinal chemistry, Mar-26, Volume: 93Neoechinulin B and its analogues as potential entry inhibitors of influenza viruses, targeting viral hemagglutinin.
AID1225534Toxicity in brine shrimp assessed as mortality2015Journal of natural products, Apr-24, Volume: 78, Issue:4
Rubrumazines A-C, Indolediketopiperazines of the Isoechinulin Class from Eurotium rubrum MA-150, a Fungus Obtained from Marine Mangrove-Derived Rhizospheric Soil.
AID1200498Inhibition of influenza A virus A/WSN/33 (H1N1) Hemagglutinin 1 binding to sialic acid receptor assessed as response unit at 20 ug/ml by surface plasmon resonance assay2015European journal of medicinal chemistry, Mar-26, Volume: 93Neoechinulin B and its analogues as potential entry inhibitors of influenza viruses, targeting viral hemagglutinin.
AID1200482Antiviral activity against influenza A virus A/WSN/33 (H1N1) infected in MDCK cells assessed as reduction in cytopathic effect at 100 uM after 48 hrs by plaque assay2015European journal of medicinal chemistry, Mar-26, Volume: 93Neoechinulin B and its analogues as potential entry inhibitors of influenza viruses, targeting viral hemagglutinin.
AID318607Cytotoxicity against human BXPC3 cells assessed as concentration required for 50% inhibition2008Journal of natural products, Mar, Volume: 71, Issue:3
Antineoplastic agents. 536. New sources of naturally occurring cancer cell growth inhibitors from marine organisms, terrestrial plants, and microorganisms(1a,).
AID1320314Inhibition of melanogenesis in theophylline-stimulated mouse B16-4A5 cells assessed as reduction in melanin level incubated for 72 hrs2016Bioorganic & medicinal chemistry letters, 10-15, Volume: 26, Issue:20
Conditional changes enhanced production of bioactive metabolites of marine derived fungus Eurotium rubrum.
AID1200499Inhibition of influenza A virus A/WSN/33 (H1N1) Hemagglutinin 1 binding to sialic acid receptor assessed as response unit at 10 ug/ml by surface plasmon resonance assay2015European journal of medicinal chemistry, Mar-26, Volume: 93Neoechinulin B and its analogues as potential entry inhibitors of influenza viruses, targeting viral hemagglutinin.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (35.00)29.6817
2010's11 (55.00)24.3611
2020's2 (10.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.65

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.65 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index4.70 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.65)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]